Journal of Nuclear Medicine · 2014 · 123 citations · 11 references
MedicineRadiologyBiomedical ImagingDiagnostic ImagingDiagnostic RadiologyBody CompositionBody ImagingComputed TomographyHepatobiliary ImagingLiver ImagingPositron Emission TomographyComputed Tomography Body CompositionCorrelationDecay-corrected Standardized Uptake ValuePet QuantificationWhole-body Lean MassWhole-body Pet Imaging
UNLABELLED: Standardized uptake value (SUV) normalized by lean body mass ([LBM] SUL) is becoming a popular metric for quantitative assessment of clinical PET. Sex-specific quantitative effects of different LBM formulations on liver SUV have not been well studied. METHODS: (18)F-FDG PET/CT scans from 1,033 consecutive adult (501 women, 532 men) studies were reviewed. Liver SUV was measured with a 3-cm-diameter spheric region of interest in the right hepatic lobe and corrected for LBM using the sex-specific James and Janmahasatian formulations. RESULTS: Body weight was 71.0 ± 20.7 kg (range, 18.0-175.0 kg) and 82.9 ± 18.6 kg (range, 23.0-159.0 kg) for women and men, respectively. SUV, based on body weight, has a significantly positive correlation with weight for both women (r = 0.58, P < 0.0001) and men (r = 0.54, P < 0.0001). This correlation is reduced in men (r = 0.11, P = 0.01) and becomes negative for women (r = -0.35, P = 0.0001) with the James formulation of SUL. This negative correlation was eliminated when the very obese women (body mass index ≥ 35) were excluded from the analysis (r = 0.13, P = 0.8). The Janmahasatian formulation annuls the correlation between SUL and weight for women (r = 0.04, P = 0.4) and decreases it for men (r = 0.13, P = 0.003). CONCLUSION: Hepatic correction with the more common James formulation for body lean mass breaks down and shows low SUL values in very obese patients. The adoption of the Janmahasatian formula for estimation of LBM in modern PET scanners and display workstations is recommended, in view of the increasing frequency of obesity.
11
Recommendations on the Use of <sup>18</sup>F-FDG PET in Oncology
James Fletcher, Benjamin Djulbegović, Heloisa P. Soares et al. · Journal of Nuclear Medicine · 2008 · 1.1K citations · Full text
Medicine, Oncology, Cancer Screening +14
Quantification of Lean Bodyweight
Sarayut Janmahasatian, Stephen B. Duffull, Susan Ash et al. · Clinical Pharmacokinetics · 2005 · 896 citations
A FLUORINATED GLUCOSE ANALOG, 2-FLUORO-2-DEOXY-D-GLUCOSE (F-18)
P. Som, Harold Atkins, D. Bandoypadhyay et al. · Journal of Computer Assisted Tomography · 1980 · 503 citations
Use of PET for monitoring cancer therapy and for predicting outcome.
Wolfgang Weber · PubMed · 2005 · 342 citations
Medicine, Nuclear Medicine, Oncology +17